| Literature DB >> 33257810 |
Yuan Kei Ching1, Yit Siew Chin2,3, Mahenderan Appukutty4, Wan Ying Gan1, Yoke Mun Chan1,5.
Abstract
Our study aimed to compare the ability of anthropometric obesity indices to predict MetS and to determine the sex-specific optimal cut-off values for MetS among Malaysian vegetarians. Body weight, height, waist circumference (WC), blood pressure (BP), fasting venous blood sample were collected from 273 vegetarians in Selangor and Kuala Lumpur, Malaysia. The abilities of body mass index (BMI), body fat percentage (BF%), waist to height ratio (WHtR), lipid accumulation product (LAP), visceral adiposity index (VAI), a body shape index (ABSI), and body roundness index (BRI) to identify MetS were tested using receiver operating characteristic (ROC) curve analyses. MetS was defined according to the Joint Interim Statement 2009. The ROC curve analyses show that BMI, BF%, WHtR, LAP and VAI were able to discriminate MetS in both sexes. LAP was a better predictor to predict MetS, followed by WHtR for male and female vegetarians. The suggested WHtR's optimal cut-offs and LAP's optimal cut-offs for MetS for male and female vegetarians were 0.541, 0.532, 41.435 and 21.743, respectively. In conclusion, LAP was a better predictor to predict MetS than other anthropometric obesity indices. However, WHtR could be an alternative obesity index in large epidemiology survey due to its convenient and cost-effective characteristics.Entities:
Year: 2020 PMID: 33257810 PMCID: PMC7705716 DOI: 10.1038/s41598-020-78035-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of the vegetarians (n = 273).
| Variables | Male ( | Female ( | ||||
|---|---|---|---|---|---|---|
| Non-MetS ( | MetS ( | Non-MetS ( | MetS ( | |||
| Age | 44.6 ± 14.7 | 49.3 ± 13.5 | 0.150 | 47.3 ± 13.0 | 52.4 ± 7.9 | 0.003* |
| Age groupsa | 0.374 | 0.065 | ||||
| 18–39 | 23 (76.7) | 7 (23.3) | 34 (94.4) | 2 (5.6) | ||
| 40–49 | 19 (76.0) | 6 (24.0) | 41 (77.4) | 12 (22.6) | ||
| 50–59 | 13 (56.5) | 10 (43.5) | 41 (73.2) | 15 (26.8) | ||
| ≥ 60 | 13 (72.2) | 5 (27.8) | 23 (71.9) | 9 (28.1) | ||
| 0.054 | 0.007* | |||||
| Chinese | 34 (81.0) | 8 (19.0) | 92 (85.2) | 16 (14.8) | ||
| Indians | 34 (63.0) | 20 (37.0) | 47 (68.1) | 22 (31.9) | ||
| 0.518 | ||||||
| Non-smoker | 61 (70.9) | 25 (29.1) | 0.981 | 137 (78.7) | 37 (21.3) | |
| Past smoker | 7 (70.0) | 3 (30.0) | 2 (66.7) | 1 (33.3) | ||
| 0.717 | 0.579 | |||||
| Yes | 6 (66.7) | 3 (33.3) | 128 (78.0) | 36 (22.0) | ||
| No | 62 (71.3) | 25 (28.7) | 11 (84.6) | 2 (15.4) | ||
| 0.431 | 0.072 | |||||
| Insufficient physical activity | 24 (64.9) | 13 (35.1) | 76 (85.4) | 13 (14.6) | ||
| Moderately active | 26 (78.8) | 7 (21.2) | 46 (73.0) | 17 (27.0) | ||
| Highly active | 18 (69.2) | 8 (30.8) | 17 (68.0) | 8 (32.0) | ||
| Body weight (kg) | 68.7 ± 11.3 | 78.9 ± 12.5 | 0.0001* | 54.7 ± 9.0 | 66.7 ± 11.7 | 0.0001* |
| Height (cm) | 170.6 ± 7.0 | 169.2 ± 6.3 | 0.346 | 157.3 ± 6.3 | 157.1 ± 6.0 | 0.825 |
| WC (cm) | 85.6 ± 9.8 | 98.8 ± 10.7 | 0.0001* | 75.6 ± 8.5 | 88.7 ± 9.0 | 0.0001* |
| BMI (kg/m2) | 23.7 ± 4.1 | 27.7 ± 3.8 | 0.0001* | 22.1 ± 3.2 | 26.9 ± 3.7 | 0.0001* |
| BF (%) | 24.5 ± 6.6 | 29.8 ± 4.2 | 0.0001* | 30.9 ± 5.8 | 36.9 ± 4.7 | 0.0001* |
| WHtR | 0.503 ± 0.063 | 0.584 ± 0.061 | 0.0001* | 0.481 ± 0.562 | 0.565 ± 0.054 | 0.0001* |
| LAP | 26.780 ± 16.650 | 75.3 ± 35.1 | 0.0001* | 17.382 ± 11.192 | 63.529 ± 52.647 | 0.0001* |
| VAI | 1.501 ± 1.038 | 3.222 ± 1.537 | 0.0001* | 1.369 ± 0.825 | 3.789 ± 3.479 | 0.0001* |
| ABSI | 0.799 ± 0.557 | 0.832 ± 0.534 | 0.011* | 0.769 ± 0.049 | 0.790 ± 0.042 | 0.017* |
| BRI | 2.123 ± 0.302 | 2.177 ± 0.260 | 0.405 | 2.727 ± 0.334 | 2.737 ± 0.294 | 0.874 |
| SBP (mmHg) | 128.6 ± 16.4 | 139.5 ± 13.3 | 0.002* | 123.0 ± 19.2 | 136.3 ± 15.7 | 0.0001* |
| DBP (mmHg) | 77.1 ± 11.1 | 84.0 ± 9.1 | 0.004* | 72.0 ± 9.1 | 81.7 ± 10.4 | 0.0001* |
| FBG (mmol/L) | 4.9 ± 0.9 | 6.2 ± 2.5 | 0.0001* | 4.7 ± 0.6 | 5.9 ± 1.6 | 0.0001* |
| TC (mmol/L) | 5.0 ± 1.1 | 5.5 ± 0.8 | 0.047* | 4.7 ± 0.8 | 5.3 ± 1.0 | 0.001* |
| TG (mmol/L) | 1.3 ± 0.9 | 2.3 ± 1.0 | 0.0001* | 0.9 ± 0.5 | 2.2 ± 1.9 | 0.001* |
| LDL-c (mmol/L) | 3.2 ± 1.0 | 3.2 ± 1.1 | 0.899 | 2.9 ± 0.7 | 3.1 ± 1.1 | 0.334 |
| HDL-c (mmol/L) | 1.2 ± 0.2 | 1.0 ± 0.2 | 0.0001* | 1.4 ± 0.2 | 1.1 ± 0.2 | 0.0001* |
| 0.0001* | 0.0001* | |||||
| Yes | 20 (50.0) | 20 (50.0) | 29 (50.9) | 28 (49.1) | ||
| No | 48 (85.7) | 8 (14.3) | 110 (91.7) | 10 (8.3) | ||
| 0.0001* | 0.0001* | |||||
| Yes | 18 (43.9) | 23 (56.1) | 42 (53.8) | 36 (46.2) | ||
| No | 50 (90.9) | 5 (9.1) | 97 (98.0) | 2 (2.0) | ||
| 0.001* | 0.0001* | |||||
| Yes | 34 (58.6) | 24 (41.4) | 47 (62.7) | 28 (37.3) | ||
| No | 34 (89.5) | 4 (10.5) | 92 (90.2) | 10 (9.8) | ||
| 0.0001* | 0.0001* | |||||
| Yes | 8 (35.4) | 14 (63.6) | 9 (32.1) | 19 (67.9) | ||
| No | 60 (81.1) | 14 (18.9) | 130 (87.2) | 19 (12.8) | ||
| 0.0001* | 0.0001* | |||||
| Yes | 13 (36.1) | 23 (63.9) | 11 (35.5) | 20 (64.5) | ||
| No | 55 (91.7) | 5 (17.9) | 128 (87.7) | 18 (12.3) | ||
| 0.0001* | 0.0001* | |||||
| Yes | 5 (27.8) | 13 (72.2) | 37 (55.2) | 30 (44.8) | ||
| No | 63 (80.8) | 15 (19.2) | 102 (92.7) | 8 (7.3) | ||
Variables are presented as Mean ± SD and n (%).
MetS metabolic syndrome, WC waist circumference, BMI body mass index, BF% body fat percentage, WHtR waist-to-height ratio, LAP lipid accumulation product, VAI visceral adiposity index, ABSI a body shape index, BRI body roundness index, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, TC total cholesterol, TG triglyceride, LDL-c low-density lipoprotein cholesterol, HDL-c high-density lipoprotein cholesterol, OW overweight, OB obesity.
*Indicates a significant difference at p < 0.05 by Chi-square test or Independent samples t-test.
aAge groups were merged into three categories to perform valid Chi-square analysis, with value reported in 2 and p.
bVariables were tested using Fisher Exact test due to the cells had expected count of less than 5.
AUCs, optimal cut-off, sensitivity, specificity for obesity indices based on the ROC curve analysis in identifying MetS and its components among male vegetarians (n = 96).
| AUC (95% CI) | YI | Cut-off | Sn (%) | Sp (%) | PPV | NPV | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| BMI (kg/m2) | 0.777 (0.686–0.868) | 0.0001* | 0.471 | 23.000 | 1.000 | 0.471 | 0.438 | 1.000 | 0.168 | – |
| BF% | 0.782 (0.685–0.878) | 0.0001* | 0.536 | 28.050 | 0.786 | 0.750 | 0.564 | 0.895 | 0.361 | – |
| WHtR | 0.825 (0.739–0.910) | 0.0001* | 0.571 | 0.541 | 0.821 | 0.750 | 0.575 | 0.911 | – | – |
| LAP | 0.923 (0.867–0.980) | 0.029* | 0.710 | 41.435 | 0.857 | 0.853 | 0.706 | 0.935 | – | – |
| VAI | 0.864 (0.786–0.942) | 0.040* | 0.660 | 2.231 | 0.821 | 0.838 | 0.677 | 0.919 | – | 0.044* |
| ABSI | 0.652 (0.534–0.770) | 0.060 | 0.252 | 0.780 | 0.679 | 0.574 | 0.396 | 0.812 | – | 0.0001* |
| BRI | 0.583 (0.457–0.709) | 0.064 | 0.208 | 2.248 | 0.429 | 0.779 | 0.445 | 0.768 | – | 0.0001* |
BMI body mass index, BF% body fat percentage, WHtR waist-to-height ratio, LAP lipid accumulation product, VAI visceral adiposity index, ABSI a body shape index, BRI body roundness index, AUC area under the curve, 95% CI 95% confidence interval, YI Youden’s Index, Sn sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value.
*Indicates a significant difference at p < 0.05 by ROC analysis.
aAbility of each index to separate MetS and non-MetS.
bComparison of the AUC value of WHtR with BMI and BF%.
cComparison of the AUC value of LAP with VAI, ABSI and BRI.
Figure 1ROC curve analysis of anthropometric obesity indices to predict MetS among male vegetarians. BMI body mass index, BF% body fat percentage, WHtR waist-to-height ratio, LAP lipid accumulation product, VAI visceral adiposity index, ABSI a body shape index, BRI body roundness index, ROC curve receiver operating characteristic curve, MetS metabolic syndrome.
AUCs, optimal cut-off, sensitivity, specificity for obesity indices based on the ROC curve analysis in identifying MetS among female vegetarians (n = 177).
| AUC (95% CI) | YI | Cut-off | Sn (%) | Sp (%) | PPV | NPV | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| BMI (kg/m2) | 0.847 (0.782–0.913) | 0.0001* | 0.576 | 24.050 | 0.842 | 0.734 | 0.464 | 0.944 | 0.503 | – |
| BF% | 0.785 (0.708–0.863) | 0.0001* | 0.437 | 34.500 | 0.711 | 0.727 | 0.416 | 0.902 | 0.006* | – |
| WHtR | 0.863 (0.797–0.928) | 0.0001* | 0.614 | 0.532 | 0.816 | 0.799 | 0.526 | 0.941 | – | – |
| LAP | 0.920 (0.862–0.977) | 0.0001* | 0.652 | 21.743 | 0.947 | 0.705 | 0.468 | 0.980 | – | – |
| VAI | 0.882 (0.818–0.947) | 0.0001* | 0.713 | 1.965 | 0.842 | 0.871 | 0.640 | 0.953 | – | 0.143 |
| ABSI | 0.636 (0.536–0.735) | 0.010* | 0.250 | 0.777 | 0.632 | 0.619 | 0.312 | 0.860 | – | 0.0001* |
| BRI | 0.537 (0.436–0.639) | 0.480 | 0.154 | 2.714 | 0.579 | 0.576 | 0.272 | 0.833 | – | 0.0001* |
BMI body mass index, BF% body fat percentage, WHtR waist-to-height ratio, LAP lipid accumulation product, VAI visceral adiposity index, ABSI a body shape index, BRI body roundness index, AUC area under the curve, 95% CI 95% confidence interval, YI Youden’s Index, Sn sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value.
*Indicates a significant difference at p < 0.05 by ROC analysis.
aAbility of each index to separate MetS and non-MetS.
bComparison of the AUC value of WHtR with BMI and BF%
cComparison of the AUC value of LAP with VAI, ABSI and BRI.
Figure 2ROC curve analysis of anthropometric obesity indices to predict MetS among female vegetarians. BMI body mass index, BF% body fat percentage, WHtR waist-to-height ratio, LAP lipid accumulation product, VAI visceral adiposity index, ABSI a body shape index, BRI body roundness index, ROC curve receiver operating characteristic curve, MetS metabolic syndrome.
Further comparison between the ability of WHtR and LAP to predict MetS in both sexes.
| WHtR’s AUC | LAP’s AUC | WHtR’s AUC–LAP’s AUC | Difference (%) | ||
|---|---|---|---|---|---|
| Male (n = 96) | 0.825 | 0.923 | − 0.098 | 11.9 | 0.016* |
| Female (n = 177) | 0.863 | 0.920 | − 0.057 | 6.6 | 0.012** |
WHtR waist-to-height ratio, LAP lipid accumulation product, AUC area under the curve, 95% CI 95% confidence interval, YI Youden’s Index, Sn sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value.
*Indicates a significant difference at p < 0.05 by ROC analysis.